Literature DB >> 29184675

Possible application of circulating free tumor DNA in non-small cell lung cancer patients.

Niki Karachaliou1,2, Aaron E Sosa1, Miguel Angel Molina3, Margarita Centelles Ruiz4, Rafael Rosell1,2,5,6.   

Abstract

Liquid biopsies have been heralded as a game changer in cancer management. Blood tests offer a minimally invasive, safe and sensitive complementary (or even alternative) approach for tissue biopsies. With lung cancer being the second most commonly diagnosed cancer and the leading cause of cancer deaths worldwide, due to the limitations of tissue sampling, liquid biopsies must urgently materialize in the clinic. In this short review, we will present the current applications of cell-free DNA (cfDNA) in lung cancer management, emphasizing on our own experience and previous work. We will also shortly comment on the challenges and need for a coordinated collaboration combining disciplines and sectors (from academia to health economies) in order to accelerate liquid biopsy development in lung cancer and other cancers.

Entities:  

Keywords:  Lung cancer; cell-free DNA (cfDNA); epidermal growth factor receptor (EGFR); liquid biopsies

Year:  2017        PMID： 29184675      PMCID： PMC5676104          DOI： 10.21037/jtd.2017.09.59

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  63 in total

1.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

2.  Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.

Authors:  Adrian G Sacher; Cloud Paweletz; Suzanne E Dahlberg; Ryan S Alden; Allison O'Connell; Nora Feeney; Stacy L Mach; Pasi A Jänne; Geoffrey R Oxnard
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

3.  O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Authors:  Carme Balaña; Jose Luis Ramirez; Miquel Taron; Yannis Roussos; Aurelio Ariza; Rosa Ballester; Carme Sarries; Pedro Mendez; Jose Javier Sanchez; Rafael Rosell
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

4.  Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers.

Authors:  Takeo Fujii; Afsaneh Barzi; Andrea Sartore-Bianchi; Andrea Cassingena; Giulia Siravegna; Daniel D Karp; Sarina A Piha-Paul; Vivek Subbiah; Apostolia M Tsimberidou; Helen J Huang; Silvio Veronese; Federica Di Nicolantonio; Sandeep Pingle; Cecile Rose T Vibat; Saege Hancock; David Berz; Vladislava O Melnikova; Mark G Erlander; Rajyalakshmi Luthra; E Scott Kopetz; Funda Meric-Bernstam; Salvatore Siena; Heinz-Josef Lenz; Alberto Bardelli; Filip Janku
Journal:  Clin Cancer Res       Date:  2017-01-17       Impact factor: 12.531

5.  Direct detection of early-stage cancers using circulating tumor DNA.

Authors:  Jillian Phallen; Mark Sausen; Vilmos Adleff; Alessandro Leal; Carolyn Hruban; James White; Valsamo Anagnostou; Jacob Fiksel; Stephen Cristiano; Eniko Papp; Savannah Speir; Thomas Reinert; Mai-Britt Worm Orntoft; Brian D Woodward; Derek Murphy; Sonya Parpart-Li; David Riley; Monica Nesselbush; Naomi Sengamalay; Andrew Georgiadis; Qing Kay Li; Mogens Rørbæk Madsen; Frank Viborg Mortensen; Joost Huiskens; Cornelis Punt; Nicole van Grieken; Remond Fijneman; Gerrit Meijer; Hatim Husain; Robert B Scharpf; Luis A Diaz; Siân Jones; Sam Angiuoli; Torben Ørntoft; Hans Jørgen Nielsen; Claus Lindbjerg Andersen; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2017-08-16       Impact factor: 17.956

6.  Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

Authors:  Emmet J Jordan; Hyunjae R Kim; Maria E Arcila; David Barron; Debyani Chakravarty; JianJiong Gao; Matthew T Chang; Andy Ni; Ritika Kundra; Philip Jonsson; Gowtham Jayakumaran; Sizhi Paul Gao; Hannah C Johnsen; Aphrothiti J Hanrahan; Ahmet Zehir; Natasha Rekhtman; Michelle S Ginsberg; Bob T Li; Helena A Yu; Paul K Paik; Alexander Drilon; Matthew D Hellmann; Dalicia N Reales; Ryma Benayed; Valerie W Rusch; Mark G Kris; Jamie E Chaft; José Baselga; Barry S Taylor; Nikolaus Schultz; Charles M Rudin; David M Hyman; Michael F Berger; David B Solit; Marc Ladanyi; Gregory J Riely
Journal:  Cancer Discov       Date:  2017-03-23       Impact factor: 39.397

7.  Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients.

Authors:  M Sánchez-Céspedes; M Monzó; R Rosell; A Pifarré; R Calvo; M P López-Cabrerizo; J Astudillo
Journal:  Ann Oncol       Date:  1998-01       Impact factor: 32.976

8.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

Review 9.  KRAS mutations in lung cancer.

Authors:  Niki Karachaliou; Clara Mayo; Carlota Costa; Ignacio Magrí; Ana Gimenez-Capitan; Miguel Angel Molina-Vila; Rafael Rosell
Journal:  Clin Lung Cancer       Date:  2012-11-01       Impact factor: 4.785

10.  Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.

Authors:  R Jonas A Nilsson; Niki Karachaliou; Jordi Berenguer; Ana Gimenez-Capitan; Pepijn Schellen; Cristina Teixido; Jihane Tannous; Justine L Kuiper; Esther Drees; Magda Grabowska; Marte van Keulen; Danielle A M Heideman; Erik Thunnissen; Anne-Marie C Dingemans; Santiago Viteri; Bakhos A Tannous; Ana Drozdowskyj; Rafael Rosell; Egbert F Smit; Thomas Wurdinger
Journal:  Oncotarget       Date:  2016-01-05
View more
  3 in total

Review 1.  Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC.

Authors:  Niki Karachaliou; Manuel Fernandez-Bruno; Jillian Wilhelmina Paulina Bracht; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2018-12

Review 2.  Liquid biopsy for lung cancer early detection.

Authors:  Mariacarmela Santarpia; Alessia Liguori; Alessandro D'Aveni; Niki Karachaliou; Maria Gonzalez-Cao; Maria Grazia Daffinà; Chiara Lazzari; Giuseppe Altavilla; Rafael Rosell
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Utility of Circulating Cell-Free DNA in Assessing Microsatellite Instability and Loss of Heterozygosity in Breast Cancer Using Human Identification Approach.

Authors:  Norah A Al Sharhan; Safia A Messaoudi; Saranya R Babu; AbdulRauf B Chaudhary; Abdullah A Alsharm; Abdulmajeed F Alrefaei; Sultan Kadasah; Muhammad Abu-Elmagd; Mourad Assidi; Abdelbaset Buhmeida; Ángel Carracedo; Wassim Y Almawi
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.141
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.